Schedule 13G ownership disclosure

Atea Pharmaceuticals Inc

Security class unavailable · CUSIP: 04683R106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,443,887
Percent of class
11.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001086364-24-002027
Form type
SC 13G/A
Filer
Atea Pharmaceuticals, Inc.
CIK
CIK 1593899
Filed
Jan 24, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub